Inhibrx Biosciences, Inc. (INBX) stock
INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$74.18−3.48 (-4.48%)
Close on Nov 17, 2026Market cap $1.09BP/E –Yield –
Inhibrx Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Inhibrx Biosciences's price to book ratio was 235.7× on Apr 30, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 1.0× to 235.7×, with a median of 4.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 235.7× | +204.6 |
| 2025 | Dec 31, 2025 | 31.1× | +29.8 |
| 2024 | Dec 31, 2024 | 1.2× | −2.2 |
| 2023 | Dec 29, 2023 | 3.5× | −2.7 |
| 2022 | Jul 29, 2022 | 6.2× | −8.5 |
| 2021 | Dec 31, 2021 | 14.7× | +11.3 |
| 2020 | Dec 31, 2020 | 3.4× | – |
See a number that looks wrong?